Synergistic Activity of Combined FLT3-ITD and MDM2 Inhibition with Quizartinib and Milademetan in FLT3-ITD Mutant/TP53 Wild-type Acute Myeloid Leukemias
Quizartinib 和 Milademetan 联合抑制 FLT3-ITD 和 MDM2 对 FLT3-ITD 突变/TP53 野生型急性髓系白血病具有协同作用
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-24-2764
Zhang, Weiguo; Li, Li; Muftuoglu, Muharrem; Basyal, Mahesh; Togashi, Noriko; Iwanaga, Koichi; Tanzawa, Fumie; Numata, Masashi; Bixby, Dale L; Erba, Harry P; Podoltsev, Nikolai; Schiller, Gary J; Kumar, Prasanna; Lesegretain, Arnaud; Isoyama, Takeshi; Seki, Takahiko; Daver, Naval; Andreeff, Michael